[1]SIEGEL RL,MILLER KD,JEMAL A.Cancer statistics,2020 [J].CA Cancer J Clin,2020,70:7-30.
[2]DEKKER E,TANIS PJ,VLEUGELS JLA,et al.Colorectal cancer [J].Lancet,2019,394:1467-1480.
[3]LIU R,HOSSAIN MM,CHEN X,et al.Mechanoregulation of SM22α/Transgelin [J].Biochemistry,2017,56:5526-5538.
[4]DVORAKOVA M,NENUTIL R,BOUCHAL P.Transgelins,cytoskeletal proteins implicated in different aspects of cancer development [J].Expert Review of Proteomics,2014,11(2):149-165.
[5]ASSINDER SJ,STANTON JAL,PRASAD PD.Transgelin:An actin-binding protein and tumour suppressor [J].The International Journal of Biochemistry and Cell Biology,2009,41(3):482-486.
[6]ZADEH F,HANIYEH B,ZALI H,et al.Proteome profiling of low grade serous ovarian cancer [J].J Ovarian Res,2019,12 (1):64.
[7]ROBATI RY,AHMADI H,RIAHI MM,et al.Comparative proteome analysis of human esophageal cancer and adjacent normal tissues [J].Iranian Journal of Basic Medical Science,2017,20(3):265-271.
[8]CHEN Z,HE S,ZHAN Y,et al.TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation [J].EBioMedicine,2019,47:208-220.
[9]解燕川,刘琼琼,任利群,等.肌动蛋白凝胶蛋白在胃癌组织中的表达及临床意义[J].中华实验外科杂志,2016,33(5):1339-1341.
XIE YC,LIU QQ,REN LQ,et al.Expression and clinicopathological analysis of transgelin in gastric cancer [J].Chinese Journal of Experimental Surgery,2016,33(5):1339-1341.
[10]LIN Y,BUCKHAULTS PJ,LEE JR,et al.Association of the actin-binding protein transgelin with lymph node metastasis in human colorectal cancer [J].Neoplasia,2009,11(9):864-873.
[11]ZHANG J,SONG MQ,ZHU JS,et al.Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry [J].Int J Immunopathol Pharmacol,2011,24(4):849-859.
[12]ZHOU H,ZHANG Y,CHEN Q,et al.AKT and JNK signaling pathways increase the metastatic potential of colorectal cancer cells by altering transgelin expression [J].Digestive Diseases and Sciences,2016,61(4):1091-1097.
[13]KIM HJ,KANG UB,LEE H,et al.Profiling of differentially expressed proteins in stage IV Colorectal cancers with good and poor outcomes [J].Journal of Proteomics,2012,75(10):2983-2997.
[14]SUN Y,PENG W,HE W,et al.Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer [J].Journal of Experimental & Clinical Cancer Research,2018,37(1):166.
[15]HAO R,LIU Y,DU Q,et al.Transgelin-2 expression in breast cancer and its relationships with clinicopathological features and patient outcome [J].Breast Cancer,2019,26:776-783.
[16]YAKABE K,MURAKAMI A,KAJIMURA T,et al.Functional significance of transgelin-2 in uterine cervical squamous cell carcinoma [J].Journal of Obstetrics and Gynaecology Research,2016,42(5):566-572.
[17]ZHANG Y,YE Y,SHEN D,et al.Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis [J].Cancer Science,2010,101(2):523-529.
[18]周静,张彦斌,张辉,等.Transgelin-2促进结肠癌细胞迁移侵袭的机制[J].中华实验外科杂志,2016,33(9):2154-2157.
ZHOU J,ZHANG YB,ZHANG H,et al.Mechanism of transgelin-2 enhanceing invasion and migration of colon cancer cells [J].Chinese Journal of Experimental Surgery,2016,33(9):2154-2157.
[19]CHEN WS,LEUNG CM,PAN HW,et al.Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer [J].Oncology Reports,2012,28(3):1069-1076.
[20]ZHANG H,JIANG M,LIU Q,et al.miR-145-5p inhibits the proliferation and migration of bladder cancer cells by targeting TAGLN2 [J].Oncol Lett,2018,16:6355-6360.
[21]ZHAO F,ZHOU LH,GE YZ,et al.MicroRNA-133b suppresses bladder cancer malignancy by targeting TAGLN2-mediated cell cycle [J].J Cell Physiol,2019,234:4910-4923.
[22]LI LS,KIM H,RHEE H,et al.Proteomic analysis distinguishes basaloid carcinoma as a distinct subtype of nonsmall cell lung carcinoma[J].Proteomics,2010,4(11):3394-3400.
[23]YANG L,HONG Q,XU SG,et al.Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factor-κB signaling pathway [J].Mol Med Rep,2019,20:4045-4058.